IJR News - today's news from every side
block
verse
w
o
rdys
billionaire
.ai
your
list
Whiteboard
App
quizie
un
school
New Journal
Loading
Genius — OpenServe
News
Home
Popular
Congress
Genius — OpenServe
Trending
Tenax Securities Suit Sets December 28 Lead-Plaintiff Deadline
Business
— 1d
Tenax Therapeutics faces a securities class action alleging it overstated the effectiveness and prospects of its lead drug, TNX-103. The allegations followed the drug’s Phase 3 trial failure and an 89.77% share-price decline; investors have until December 28, 2026, to seek lead-plaintiff status.
+2
0
Share